calendar
3,999 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 108 grant
next 91 dayslessmore
MonWedFri
3,999 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 108 grant
no tagged catalysts yet
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: PHASE4. Conditions: Mitral Regurgitation
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Brain Tumor
Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Stroke
Sponsor: University of Florida. Phase: NA. Conditions: Essential Tremor
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla. Phase: PHASE1. Conditions: Sclerosis, Multiple, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Autoimmune Diseases
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City. Phase: NA. Conditions: Shoulder Tendinopathy, Shoulder Tendinitis
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Skin Cancer
Sponsor: University of Crete. Phase: NA. Conditions: Medication Overuse, Deprescriptions, Polypharmacy, Frailty Syndrome
Sponsor: Seoul National University Hospital. Phase: . Conditions: Adult Double Unit Cord Blood Transplant
Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Cerebral Palsy
Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Breast Neoplasms, Survivors, Chronic Pain
Sponsor: Universidad de Granada. Phase: . Conditions: COVID-19
Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Febrile Crisis
Sponsor: Johns Hopkins University. Phase: . Conditions: Ventilator Associated Pneumonia, Tracheobronchitis
Sponsor: University of Virginia. Phase: EARLY_PHASE1. Conditions: Prolonged Grief Disorder
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Intrahepatic Cholangiocarcinoma
Sponsor: International Dental Contiuing Education. Phase: NA. Conditions: Internal Sinus Lifting
Sponsor: University of Valencia. Phase: NA. Conditions: Aging, Adults With Overweight and Obesity, Supplementation, Exercise
Sponsor: Hofseth Biocare ASA. Phase: NA. Conditions: Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health
Sponsor: Monte Rosa Therapeutics, Inc. Phase: PHASE1. Conditions: NSCLC, SCLC, High Grade Neuroendocrine Cancer, DLBCL, L-MYC and N-MYC Amplified Solid Tumors, NSCLC With High or Low L-MYC or N-MYC Expression, HR-positive, HER2-negative Breast Cancer, Prostate Cancer
Sponsor: Cairo University. Phase: NA. Conditions: Sublingual, Caffeine, Recovery Time, Postoperative Agitation, Elderly Patients, General Anesthesia
Sponsor: Min Su. Phase: EARLY_PHASE1. Conditions: Esketamine, ECT, Depression, Adolescent
Sponsor: Regend Therapeutics. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Duke University. Phase: NA. Conditions: Hypertension, HIV
Sponsor: Centre Henri Becquerel. Phase: PHASE2. Conditions: Lymphoma
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Pleural Neoplasm
Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Hepato Cellular Carcinoma, Cirrhosis, Autonomic Nervous System, Central Nervous System
Sponsor: Tethis S.p.A.. Phase: . Conditions: Breast Neoplasms
Sponsor: Lahey Clinic. Phase: NA. Conditions: Cervical Spondylosis With Myelopathy
Sponsor: Boston University Charles River Campus. Phase: NA. Conditions: Parkinson's Disease (PD), Essential Tremor
Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity & Overweight, Marginal Ulcer (Peptic) or Erosion, Leakage, Anastomotic
Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Smoking Cessation
Sponsor: Dr Cipto Mangunkusumo General Hospital. Phase: NA. Conditions: Hypertension in Pregnancy
Sponsor: University of Southern Denmark. Phase: NA. Conditions: Heart Disease, Mental Health Outcomes, Rehabilitation
Sponsor: University of Southern Denmark. Phase: PHASE3. Conditions: Non-Convulsive Status Epilepticus
Sponsor: University of Salamanca. Phase: NA. Conditions: Healthy Adult Participants
Sponsor: University of Miami. Phase: PHASE4. Conditions: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder
Sponsor: University Hospital, Montpellier. Phase: . Conditions: Heart Failure
Sponsor: Baylor College of Medicine. Phase: . Conditions: Healthy Nutrition, Healthy Diet
Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm
Sponsor: Istituto Giannina Gaslini. Phase: NA. Conditions: Celiac Disease in Children, Anemia, Iron Deficiencies
Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Nonunion Fracture
Sponsor: Cue Biopharma. Phase: PHASE1. Conditions: Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Ovarian Cancer
Sponsor: Ataturk University. Phase: NA. Conditions: Laughter Yoga
Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: EDUCATION
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Hematopoietic and Lymphatic System Neoplasm, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma, Recurrent Histiocytic and Dendritic Cell Neoplasm, Recurrent Langerhans Cell Histiocytosis, Recurrent Lymphoma, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Glioma, Recurrent Malignant Solid Neoplasm, Recurrent Medulloblastoma, Recurrent Neuroblastoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Osteosarcoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Rhabdoid Tumor, Recurrent Rhabdomyosarcoma, Recurrent Soft Tissue Sarcoma, Recurrent WHO Grade 2 Glioma, Refractory Ependymoma, Refractory Ewing Sarcoma, Refractory Hepatoblastoma, Refractory Histiocytic and Dendritic Cell Neoplasm, Refractory Langerhans Cell Histiocytosis, Refractory Lymphoma, Refractory Malignant Germ Cell Tumor, Refractory Malignant Glioma, Refractory Malignant Solid Neoplasm, Refractory Medulloblastoma, Refractory Neuroblastoma, Refractory Non-Hodgkin Lymphoma, Refractory Osteosarcoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Rhabdoid Tumor, Refractory Rhabdomyosarcoma, Refractory Soft Tissue Sarcoma, Refractory WHO Grade 2 Glioma, Wilms Tumor
Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Synkinesis
Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Musculoskeletal Pain, Fibromyalgia, Healthy Controls Group - Age and Sex-matched
Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Serratus Anterior Muscle Plane Block, Transversus Thoracis Muscle Plane Block, Postoperative Analgesia